BMO Short Term US Treasury Bond Index ETF (ZTS) Noticias

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph...

Form 3 - Initial statement of beneficial ownership of securities

Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role

New Commercial Organizational Structure to Accelerate Long-Term Growth Strategy in Key Markets and Optimize...

Zoetis to Participate in Jefferies London Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Wetteny Joseph, Executive...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Zoetis Announces Third Quarter 2024 Results 

Reports Revenue of $2.4 Billion, Growing 11%, and Net Income of $682 Million, or $1.50 per Diluted Share, Increasing 14% and 16%, Respectively...

Form 8-K - Current report

Zoetis Declares Fourth Quarter 2024 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the fourth quarter of 2024. The dividend will be...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities